Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted

Journal of Investigative Dermatology

Volumn 114, Issue 2, 2000, Pages 289-294

  Yamakage, Ckohji ^a,b   Omori, Yasufumi ^a   Zaidan Dagli, Maria Lucia ^a   Cros, Marie Pierre ^a   Yamasaki, Hiroshi ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HATANO RESEARCH INSTITUTE   (Japan)

Author keywords

Gap junctional intercellular communication; Two stage carcinogenesis

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CONNEXIN 43; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; GAP JUNCTION; GENE DELETION; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; SARCOMA; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN PAPILLOMA;

EID: 1642633544     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00873.x     Document Type: Article

References (49)

1. Azarnia R, Reddy S, Kmiecik TE, Shalloway D, Loewenstein WR: The cellular src gene product regulates junctional cell-to-cell communication. Science 239:398-401, 1988
2. Bergoffen J, Scherer SS, Wang S, et al: Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042, 1993
3. Bignami M, Rosa S, Falcone G, Tato F, Katoh F, Yamasaki H: Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells. Mol Carcinog 1:67-75, 1988
4. Bizub D, Wood AV, Skalka AM: Mutagnesis of the Ha-ras oncogne in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci USA 83:6048-6052, 1986
5. Britz-Cunningham SH, Shah MM, Zuppan CW, Fletcher WH: Mutations of the connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med 332:1323-1329, 1995
6. Bruzzone R, White TW, Paul DL: Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238:1-27, 1996
7. Budunova IV, Carbajal S. Slaga TJ: The expression of gap junctional proteins during different stages of mouse skin carcinogenesis. Carcinogenesis 16:2717-2724, 1995
8. Butterweck A, Elfgang C, Willecke K, Traube O: Differential expression of the gap junction proteins connexin45-43-31, and -26 in mouse skin. Eur J Cell Biol 65:152-163, 1994
9. Eghbali B. Kessler JA, Reid LM, Roy C, Spray DC: Involvement of gap junctions in tumorigensis: Transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 88:10701-10705, 1991
10. Enomoto T, Yamasaki H: Lack of intercellular communication between chemically transformed and surrounding nontransmed BALB/c 3T3 cells. Cancer Res 44:5200-5203, 1984
11. Esinduy CB, Chang CC, Trosko JE, Ruch RJ: In vitro growth inhibition of NIXENNOCmFNIbD DNAfbbcCASAMLLmneoplastically transformed cells by non-transformed cells: Requirement for gap junctional intercellular communication. Carcinogenesis 16:915-921, 1995
12. Ewart JL, Cohen MF, Meyer RA, et al: Heart and neural tube defects in transgenic mice overexpressing the Cx43 gap junction gene. Development 124:1281-1292, 1997
13. Gabriel HD, Jung D, Butzler C, Temme A, Traub O, Winterhager E, Willecke K: Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice. J Cell Biol 140:1453-1461, 1998
14. Goldberg GS, Martyn KD, Lau AF: A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells. Mol Carcinog 11:106-114, 1994
15. Goliger JA, Paul DL: Expression of gap junction proteins Cx26, Cx31.1, Cx37 and Cx43 in developing and mature rat epidermis. Dev Dyn 200:1-13, 1994
16. Gong X, Li E, Klier G, et al: Disruption of alpha3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 91:833-843, 1997
17. Goodenough DA, Goliger JA, Paul DL: Connexins, connexons, and intercellular communication. Annu Rev Biochem 65:475-502, 1996
18. Jiang JX, Goodenough DA: Heteromeric connexons in lens gap junction channels. Proc Natl Acad Sci USA 93:1287-1291, 1996
19. Kalimi GH, Hampton LL, Trosko JE, Thorgeirsson SS, Huggett AC: Homologous and heterologous gap-junctional intercellular communication in v-raf, v-myc, and v-raf/v-myc-transduced rat liver epithelial cell lines. Mol Carcinog 5:301-310, 1992
20. Kalimi GH, Sirsat SM: Phorbol ester tumor promoter affects the mouse epidermal gap junctions. Cancer Lett 22:343-350, 1984
21. Kamibayashi Y, Oyamada Y, Mon M, Oyamada M: Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis 16:1287-1297, 1995
22. Kelsell DP, Dunlop J, Stevens HP et al: Connexin 26 mutations in hereditary nonsyndromic sensorineural deafness. Nature 387:80-83, 1997
23. Kirchhoff S, Nees E, Hagendorff A, Kruger O, Traub O, Willecke K: Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 26:299-302, 1998
24. Krutovskikh V, Mazzoleni G, Mironov N, et al: Altered homologous and heterologous gap junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 56:87-94, 1994
25. Knitovskikh V, Mironov N, Yamasaki H: Human connexin37 is polymorphic but not mutated in tumors. Carcinogenesis 17:1761-1763, 1996
26. Krutovskikh V, Yamasaki H, Tsuda H, Asamoto M: Inhibition of intrinsic gap-junction intercellular communication and enhancement of tumorigenicity of the rat bladder carcinoma cell line BC31 by a dominant-negative connexin 43 mutant. Mol Carcinog 23:254-261, 1998
27. Loewenstein W, Kanno Y: Intercellular communication and the control of the tissue growth; lack of communication between cancer cells. Nature 209:1248-1249, 1966
28. Martyn KD, Kurata WE, Warn-Cramer BJ, Burt JM, TenBroek E, Lauf AF: Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ 9:1015-1027, 1997
29. Mesnil M, Krutovskikh V, Piccoli C, et al: Negative growth control of HeLa cells by connexin genes: Connexin species specificity, Cancer Res 55:629-639, 1995
30. Mironov N, Aguelon A-M, Potapova GI, Omori Y, Gorbunov OV, Klimenkov AA, Yamasaki H: Alterations of (CA) n DNA repeats and tumor-suppressor genes in human gastric cancer. Cancer Res 54:41-44, 1994
31. Omori Y, Krutovskikh V, Mironov N, Tsuda H, Yamasaki H: Cx32 gene mutation in a chemically induced rat liver tumour. Carcinogenesis 17:2077-2080, 1996
32. Resume AG, de Sousa PA, Kulkarni S, et al: Cardiac malformation in neonatal mice lacking connexin43. Science 267:1831-1834, 1995
33. Richard G, Smith LE, Bailey RA, et al: Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 20:366-369, 1998
34. Rose B, Mehta PP, Loewenstein WR: Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis 14:1073-1075, 1993
35. Saito T, Barbin A, Omori Y, Yamasaki H: Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride. Cancer Res 57:375-377, 1997
36. Salomon D, Masgrau E, Vischer M, et al. Gap-junction proteins and communication in human epidermis. In: Hall JE, Zampighi GA, Davis RM (eds). Progress in Cell Research, Vol. 3. Gap Junctions. Amsterdam: Elsevier, 1993, pp 225-233
37. Sasaki K, Bertrand O, Nakazawa H, Fitzgerald DJ, Mironov N, Yamasaki H: Cell-type-specific ras mutations but not microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells, Cancer Res 55:3513-3516, 1995
38. Sato K, Gtatas C, Lampe J, Biernat W, Kleihues P, Yaki H, Ohgaki H: Reduced expression of the P2 form of the gap junction protein connexin43 in malignant meningiomas. J Neuropathol Exp Neurol 56:835-839, 1997
39. Sawey MJ, Goldschmidt MH, Risek B, Gilula NB, Lo SW: Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia. Mol Carinog 17:49-61, 1996
40. Simon AM, Goodneough DA, Li E, Paul DL: Female infertility in mice lacking connexin 37. Nature 385:525-529, 1997
41. 1-connxin (cexi) can from heteromeric hemichannels. J Biol Chem 270:6768-6772. 1995
42. Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M, Willecke K: High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 7:713-716, 1997
43. Trosko JE, Ruch RJ: Cell-cell communication in carcinogenesis. Front Biosc 15:D208-D236, 1998
44. Willecke K, Hennerman H, Dahl E, Jungbluth S. The mouse connexin gene family: In: Hall JE, Zampighi GA, Davis RM (eds), Progress in Cell Research, Vol. 3. Gap Junctions. Amsterdam: Elsevier, 1993, pp 33-41
45. Xia JH, Liu CY, Tang BS, et al: Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet 20:370-373, 1998
46. Yamakage K, Omori Y, Piccoli C, Yamasaki H: Growth control of 3T3 fibroblast cell line established from coimexin 43-deficient mice. Mol Carcinog 23:121-128, 1998
47. Yamasaki H: Rolf of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. Mutat Res 365:91-105, 1996
48. Yamasaki H, Katoh F: Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. Cancer Res 48:3490-3495, 1988
49. Yamasaki H, Naus CC: Role of connexin genes in growth control. Carcinogenesis 17:1199-1213, 1996